| Year |
Citation |
Score |
| 2022 |
Kanao R, Kawai H, Taniguchi T, Takata M, Masutani C. RFWD3 and translesion DNA polymerases contribute to PCNA modification-dependent DNA damage tolerance. Life Science Alliance. 5. PMID 35905994 DOI: 10.26508/lsa.202201584 |
0.346 |
|
| 2019 |
Taniguchi T. REV1-POL ζ Inhibition and Cancer Therapy. Molecular Cell. 75: 419-420. PMID 31398321 DOI: 10.1016/J.Molcel.2019.07.012 |
0.355 |
|
| 2019 |
Hu WF, Krieger KL, Lagundžin D, Li X, Cheung RS, Taniguchi T, Johnson KR, Bessho T, Monteiro ANA, Woods NT. CTDP1 regulates breast cancer survival and DNA repair through BRCT-specific interactions with FANCI. Cell Death Discovery. 5: 105. PMID 31240132 DOI: 10.1038/S41420-019-0185-3 |
0.458 |
|
| 2017 |
Cheung RS, Taniguchi T. Recent insights into the molecular basis of Fanconi anemia: genes, modifiers, and drivers. International Journal of Hematology. PMID 28631178 DOI: 10.1007/S12185-017-2283-4 |
0.377 |
|
| 2017 |
Calses PC, Dhillon KK, Tucker N, Chi Y, Huang JW, Kawasumi M, Nghiem P, Wang Y, Clurman BE, Jacquemont C, Gafken PR, Sugasawa K, Saijo M, Taniguchi T. DGCR8 Mediates Repair of UV-Induced DNA Damage Independently of RNA Processing. Cell Reports. 19: 162-174. PMID 28380355 DOI: 10.1016/J.Celrep.2017.03.021 |
0.712 |
|
| 2017 |
Taniguchi T. Abstract IA06: The Fanconi anemia-BRCA pathway and cancer Molecular Cancer Research. 15. DOI: 10.1158/1557-3125.Dnarepair16-Ia06 |
0.44 |
|
| 2016 |
Abeyta A, Castella M, Jacquemont C, Taniguchi T. NEK8 regulates DNA damage-induced RAD51 foci formation and replication fork protection. Cell Cycle (Georgetown, Tex.). 0. PMID 27892797 DOI: 10.1080/15384101.2016.1259038 |
0.473 |
|
| 2016 |
Drost R, Dhillon KK, van der Gulden H, van der Heijden I, Brandsma I, Cruz C, Chondronasiou D, Castroviejo-Bermejo M, Boon U, Schut E, van der Burg E, Wientjens E, Pieterse M, Klijn C, Klarenbeek S, ... ... Taniguchi T, et al. BRCA1185delAG tumors may acquire therapy resistance through expression of RING-less BRCA1. The Journal of Clinical Investigation. PMID 27454287 DOI: 10.1172/Jci70196 |
0.354 |
|
| 2015 |
Castella M, Jacquemont C, Thompson EL, Yeo JE, Cheung RS, Huang JW, Sobeck A, Hendrickson EA, Taniguchi T. FANCI Regulates Recruitment of the FA Core Complex at Sites of DNA Damage Independently of FANCD2. Plos Genetics. 11: e1005563. PMID 26430909 DOI: 10.1371/Journal.Pgen.1005563 |
0.707 |
|
| 2015 |
Huang JW, Pan C, Tran S, Cheng B, Watanabe K, Taniguchi T, Lau CN, Bockrath M. Superior Current Carrying Capacity of Boron Nitride Encapsulated Carbon Nanotubes with Zero-Dimensional Contacts. Nano Letters. PMID 26390365 DOI: 10.1021/Acs.Nanolett.5B02716 |
0.627 |
|
| 2014 |
Wang Y, Huang JW, Castella M, Huntsman DG, Taniguchi T. p53 is positively regulated by miR-542-3p. Cancer Research. 74: 3218-27. PMID 24762395 DOI: 10.1158/0008-5472.Can-13-1706 |
0.708 |
|
| 2014 |
Cheung RS, Castella M, Taniguchi T. Disparate Requirements for the Phosphorylation of Distinct Sites on the Fanconi Anemia Group I Protein Blood. 124: 358-358. DOI: 10.1182/Blood.V124.21.358.358 |
0.341 |
|
| 2013 |
Huang JW, Wang Y, Dhillon KK, Calses P, Villegas E, Mitchell PS, Tewari M, Kemp CJ, Taniguchi T. Systematic screen identifies miRNAs that target RAD51 and RAD51D to enhance chemosensitivity. Molecular Cancer Research : McR. 11: 1564-73. PMID 24088786 DOI: 10.1158/1541-7786.Mcr-13-0292 |
0.74 |
|
| 2013 |
Pennington KP, Wickramanayake A, Norquist BM, Pennil CC, Garcia RL, Agnew KJ, Taniguchi T, Welcsh P, Swisher EM. 53BP1 expression in sporadic and inherited ovarian carcinoma: Relationship to genetic status and clinical outcomes. Gynecologic Oncology. 128: 493-9. PMID 23246380 DOI: 10.1016/J.Ygyno.2012.12.007 |
0.354 |
|
| 2012 |
Wang Y, Taniguchi T. MicroRNAs and DNA damage response: implications for cancer therapy. Cell Cycle (Georgetown, Tex.). 12: 32-42. PMID 23255103 DOI: 10.4161/cc.23051 |
0.406 |
|
| 2012 |
Wang Y, Huang JW, Calses P, Kemp CJ, Taniguchi T. MiR-96 downregulates REV1 and RAD51 to promote cellular sensitivity to cisplatin and PARP inhibition. Cancer Research. 72: 4037-46. PMID 22761336 DOI: 10.1158/0008-5472.Can-12-0103 |
0.753 |
|
| 2012 |
Jacquemont C, Simon JA, D'Andrea AD, Taniguchi T. Non-specific chemical inhibition of the Fanconi anemia pathway sensitizes cancer cells to cisplatin. Molecular Cancer. 11: 26. PMID 22537224 DOI: 10.1186/1476-4598-11-26 |
0.421 |
|
| 2011 |
Wang Y, Huang JW, Li M, Cavenee WK, Mitchell PS, Zhou X, Tewari M, Furnari FB, Taniguchi T. MicroRNA-138 modulates DNA damage response by repressing histone H2AX expression. Molecular Cancer Research : McR. 9: 1100-11. PMID 21693595 DOI: 10.1158/1541-7786.Mcr-11-0007 |
0.758 |
|
| 2011 |
Dhillon KK, Swisher EM, Taniguchi T. Secondary mutations of BRCA1/2 and drug resistance. Cancer Science. 102: 663-9. PMID 21205087 DOI: 10.1111/J.1349-7006.2010.01840.X |
0.365 |
|
| 2010 |
Konstantinopoulos P, Spentzos D, Karlan B, Taniguchi T, Fountzilas E, Francoeur N, Levine DA, Cannistra SA. A gene expression profile of BRCAness that correlates with responsiveness to platinum and PARP inhibitors. Journal of Clinical Oncology. 28: 5004-5004. DOI: 10.1200/Jco.2010.28.15_Suppl.5004 |
0.332 |
|
| 2010 |
Huang J, Villegas E, Taniguchi T. Abstract 1951: MicroRNA-mediated regulation of the Fanconi anemia-BRCA pathway Cancer Research. 70: 1951-1951. DOI: 10.1158/1538-7445.Am10-1951 |
0.752 |
|
| 2010 |
Wang Y, Taniguchi T. Abstract 1947: Identification of microRNAs that regulate DNA damage response Cancer Research. 70: 1947-1947. DOI: 10.1158/1538-7445.Am10-1947 |
0.552 |
|
| 2009 |
Swisher EM, Gonzalez RM, Taniguchi T, Garcia RL, Walsh T, Goff BA, Welcsh P. Methylation and protein expression of DNA repair genes: association with chemotherapy exposure and survival in sporadic ovarian and peritoneal carcinomas. Molecular Cancer. 8: 48. PMID 19602291 DOI: 10.1186/1476-4598-8-48 |
0.331 |
|
| 2008 |
Sakai W, Swisher EM, Karlan BY, Agarwal MK, Higgins J, Friedman C, Villegas E, Jacquemont C, Farrugia DJ, Couch FJ, Urban N, Taniguchi T. Secondary mutations as a mechanism of cisplatin resistance in BRCA2-mutated cancers Nature. 451: 1116-1120. PMID 18264087 DOI: 10.1038/Nature06633 |
0.304 |
|
| 2007 |
Jacquemont C, Taniguchi T. The Fanconi anemia pathway and ubiquitin. Bmc Biochemistry. 8: S10. PMID 18047734 DOI: 10.1186/1471-2091-8-S1-S10 |
0.487 |
|
| 2007 |
Jacquemont C, Taniguchi T. Proteasome function is required for DNA damage response and fanconi anemia pathway activation. Cancer Research. 67: 7395-405. PMID 17671210 DOI: 10.1158/0008-5472.Can-07-1015 |
0.463 |
|
| 2007 |
Chen CC, Taniguchi T, D'Andrea A. The Fanconi anemia (FA) pathway confers glioma resistance to DNA alkylating agents Journal of Molecular Medicine. 85: 497-509. PMID 17221219 DOI: 10.1007/S00109-006-0153-2 |
0.436 |
|
| 2006 |
Ho GP, Margossian S, Taniguchi T, D'Andrea AD. Phosphorylation of FANCD2 on two novel sites is required for mitomycin C resistance. Molecular and Cellular Biology. 26: 7005-15. PMID 16943440 DOI: 10.1128/Mcb.02018-05 |
0.417 |
|
| 2006 |
Chirnomas D, Taniguchi T, de la Vega M, Vaidya AP, Vasserman M, Hartman AR, Kennedy R, Foster R, Mahoney J, Seiden MV, D'Andrea AD. Chemosensitization to cisplatin by inhibitors of the Fanconi anemia/BRCA pathway. Molecular Cancer Therapeutics. 5: 952-61. PMID 16648566 DOI: 10.1158/1535-7163.Mct-05-0493 |
0.418 |
|
| 2006 |
Taniguchi T, D'Andrea AD. Molecular pathogenesis of Fanconi anemia: recent progress. Blood. 107: 4223-33. PMID 16493006 DOI: 10.1182/Blood-2005-10-4240 |
0.444 |
|
| 2006 |
Mankad A, Taniguchi T, Cox B, Akkari Y, Rathbun RK, Lucas L, Bagby G, Olson S, D'Andrea A, Grompe M. Natural gene therapy in monozygotic twins with Fanconi anemia. Blood. 107: 3084-90. PMID 16397136 DOI: 10.1182/Blood-2005-07-2638 |
0.308 |
|
| 2005 |
Houghtaling S, Newell A, Akkari Y, Taniguchi T, Olson S, Grompe M. Fancd2 functions in a double strand break repair pathway that is distinct from non-homologous end joining. Human Molecular Genetics. 14: 3027-33. PMID 16135554 DOI: 10.1093/Hmg/Ddi334 |
0.442 |
|
| 2005 |
Howlett NG, Taniguchi T, Durkin SG, D'Andrea AD, Glover TW. The Fanconi anemia pathway is required for the DNA replication stress response and for the regulation of common fragile site stability. Human Molecular Genetics. 14: 693-701. PMID 15661754 DOI: 10.1093/Hmg/Ddi065 |
0.454 |
|
| 2005 |
Nakanishi K, Yang YG, Pierce AJ, Taniguchi T, Digweed M, D'Andrea AD, Wang ZQ, Jasin M. Human Fanconi anemia monoubiquitination pathway promotes homologous DNA repair. Proceedings of the National Academy of Sciences of the United States of America. 102: 1110-5. PMID 15650050 DOI: 10.1073/Pnas.0407796102 |
0.476 |
|
| 2005 |
Montes de Oca R, Andreassen PR, Margossian SP, Gregory RC, Taniguchi T, Wang X, Houghtaling S, Grompe M, D'Andrea AD. Regulated interaction of the Fanconi anemia protein, FANCD2, with chromatin. Blood. 105: 1003-9. PMID 15454491 DOI: 10.1182/Blood-2003-11-3997 |
0.356 |
|
| 2004 |
Andreassen PR, D'Andrea AD, Taniguchi T. ATR couples FANCD2 monoubiquitination to the DNA-damage response. Genes & Development. 18: 1958-63. PMID 15314022 DOI: 10.1101/Gad.1196104 |
0.44 |
|
| 2003 |
Tischkowitz M, Ameziane N, Waisfisz Q, De Winter JP, Harris R, Taniguchi T, D'Andrea A, Hodgson SV, Mathew CG, Joenje H. Bi-allelic silencing of the Fanconi anaemia gene FANCF in acute myeloid leukaemia. British Journal of Haematology. 123: 469-71. PMID 14617007 DOI: 10.1046/J.1365-2141.2003.04640.X |
0.303 |
|
| 2003 |
Taniguchi T, Tischkowitz M, Ameziane N, Hodgson SV, Mathew CG, Joenje H, Mok SC, D'Andrea AD. Disruption of the Fanconi anemia-BRCA pathway in cisplatin-sensitive ovarian tumors. Nature Medicine. 9: 568-74. PMID 12692539 DOI: 10.1038/Nm852 |
0.336 |
|
| 2003 |
Gregory RC, Taniguchi T, D'Andrea AD. Regulation of the Fanconi anemia pathway by monoubiquitination. Seminars in Cancer Biology. 13: 77-82. PMID 12507559 DOI: 10.1016/S1044-579X(02)00102-5 |
0.448 |
|
| 2002 |
Nakanishi K, Taniguchi T, Ranganathan V, New HV, Moreau LA, Stotsky M, Mathew CG, Kastan MB, Weaver DT, D'Andrea AD. Interaction of FANCD2 and NBS1 in the DNA damage response. Nature Cell Biology. 4: 913-20. PMID 12447395 DOI: 10.1038/Ncb879 |
0.394 |
|
| 2002 |
Adachi D, Oda T, Yagasaki H, Nakasato K, Taniguchi T, D'Andrea AD, Asano S, Yamashita T. Heterogeneous activation of the Fanconi anemia pathway by patient-derived FANCA mutants. Human Molecular Genetics. 11: 3125-34. PMID 12444097 DOI: 10.1093/Hmg/11.25.3125 |
0.407 |
|
| 2002 |
Taniguchi T, D'Andrea AD. The Fanconi anemia protein, FANCE, promotes the nuclear accumulation of FANCC. Blood. 100: 2457-62. PMID 12239156 DOI: 10.1182/Blood-2002-03-0860 |
0.355 |
|
| 2002 |
Taniguchi T, Garcia-Higuera I, Andreassen PR, Gregory RC, Grompe M, D'Andrea AD. S-phase-specific interaction of the Fanconi anemia protein, FANCD2, with BRCA1 and RAD51. Blood. 100: 2414-20. PMID 12239151 DOI: 10.1182/Blood-2002-01-0278 |
0.428 |
|
| 2002 |
Taniguchi T, Garcia-Higuera I, Xu B, Andreassen PR, Gregory RC, Kim ST, Lane WS, Kastan MB, D'Andrea AD. Convergence of the fanconi anemia and ataxia telangiectasia signaling pathways. Cell. 109: 459-72. PMID 12086603 DOI: 10.1016/S0092-8674(02)00747-X |
0.374 |
|
| 2002 |
Howlett NG, Taniguchi T, Olson S, Cox B, Waisfisz Q, De Die-Smulders C, Persky N, Grompe M, Joenje H, Pals G, Ikeda H, Fox EA, D'Andrea AD. Biallelic inactivation of BRCA2 in Fanconi anemia. Science (New York, N.Y.). 297: 606-9. PMID 12065746 DOI: 10.1126/Science.1073834 |
0.355 |
|
| 2002 |
Taniguchi T, Dandrea AD. Molecular pathogenesis of fanconi anemia. International Journal of Hematology. 75: 123-8. PMID 11939257 DOI: 10.1007/Bf02982016 |
0.431 |
|
| 2001 |
Siddique MA, Nakanishi K, Taniguchi T, Grompe M, D'Andrea AD. Function of the Fanconi anemia pathway in Fanconi anemia complementation group F and D1 cells. Experimental Hematology. 29: 1448-55. PMID 11750104 DOI: 10.1016/S0301-472X(01)00754-8 |
0.334 |
|
| 2001 |
Garcia-Higuera I, Taniguchi T, Ganesan S, Meyn MS, Timmers C, Hejna J, Grompe M, D'Andrea AD. Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway. Molecular Cell. 7: 249-62. PMID 11239454 DOI: 10.1016/S1097-2765(01)00173-3 |
0.432 |
|
| 1998 |
Uchimaru K, Taniguchi T, Yoshikawa M, Fujinuma H, Fujita T, Motokura T. Growth arrest associated with 12-o-tetradecanoylphorbol-13-acetate-induced hematopoietic differentiation with a defective retinoblastoma tumor suppressor-mediated pathway Leukemia Research. 22: 413-420. PMID 9652727 DOI: 10.1016/S0145-2126(98)00004-6 |
0.358 |
|
| Show low-probability matches. |